Press Releases Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Delayed London S.E. Other stock markets 10:42:18 2024-06-10 am EDT			5-day change	1st Jan Change
13.47 ^GBX	-2.04%		-5.47%	+48.84%

May. 01	Poolbeg Pharma Secures Full Patent in US for Immunomodulator II	MT
May. 01	Poolbeg Pharma celebrates full patent approval for Immunomodulator II	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poolbeg Pharma plc - Annual Report and AGM Notice	May. 10	AQ
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office	May. 08	AQ
Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug	May. 01	AQ
Poolbeg Pharma plc - Appointment of Joint Broker	May. 01	AQ
Poolbeg Pharma plc - Director Share Purchase	Feb. 23	AQ
Poolbeg Pharma plc - Director Share Purchase	Feb. 20	AQ
Poolbeg Pharma chair discusses shift to executive role; hVIVO share sale	Feb. 20	AQ
Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies	Feb. 12	AQ
Poolbeg Pharma's new VP of Clinical Operations Laura Maher aims to help progress development assets	Feb. 08	AQ
Poolbeg Pharma plc - Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome	Jan. 18	AQ
Poolbeg Pharma plc - POLB 001 Data Presented at ASH	Dec. 12	AQ
Poolbeg Pharma plc - Immunomodulator II patent granted in Japan	Nov. 22	AQ
Poolbeg Pharma plc - POLB 001 LPS Challenge Trial Data to be presented at IUIS	Nov. 17	AQ
Poolbeg Pharma "continuing its campaign to find a partner" for POLB001	Nov. 02	AQ
Poolbeg Pharma unveils new collaboration agreement	23-10-18	AQ
Poolbeg Pharma "moving forward rapidly" with POLB001	23-09-13	AQ
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"	23-06-29	AQ
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines	23-06-22	AQ
Poolbeg Pharma's new NED looking at "new opportunities" for the business	23-05-26	AQ
Poolbeg Pharma "in a very healthy cash position" after first full year of operations	23-03-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Press Releases

Filters